Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jan, 2019 | Pages:
80 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)
The global nutrigenomics market size is expected to reach USD 850.86 million by 2025 registering a CAGR of 16.48%, according to a new report by Grand View Research, Inc. This growth can be attributed to the rising cases of obesity and Cardiovascular Diseases (CVDs), particularly in developed regions. Nutrigenomics can play a vital role in the prevention of obesity by offering personalized, gene-based diet. Increased awareness about the product along with growing geriatric population will also augment the market growth. Obesity and cancer research applications of nutrigenomics emerged as the market leaders in 2017 and are expected to maintain the dominance expanding at a significant CAGR over the forecast period. Developing regional markets including Asia Pacific, Latin America, and Middle East are also expected to witness rapid expansion owing to the increased cases of obesity and growing geriatric population. Further key findings from the study suggest: • The global nutrigenomics demand exceeded USD 250 million in 2017 and is expected to expand at a CAGR of 16.48% over the forecast period • Obesity application segment led the market in 2017 and is estimated to account for a 38% of the industry share by 2025 • North America accounted for the largest market share in 2017 and is estimated to maintain its dominance over the years to come • The Asia Pacific market is projected to witness substantial growth over the next decade owing to increasing cases of obesity and CVD-related deaths • Key participants in the global nutrigenomics market include Koninklijke DSM N.V. (Royal DSM); BASF SE; Danone; GeneSmart; Unilever; Genova Diagnostics; Inc.; Nutrigenomix, Inc.; Metagenics, Inc.; WellGen, Inc.; and Cell Logic
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Nutrigenomics Market Variables, Trends& Scope
3.1 Market segmentation& scope
3.1.1 Market Driver Analysis
3.1.1.1 Increasing prevalence of obesity
3.1.1.2 Increasing popularity for personalized diet
3.1.1.3 Intense research for cancer prevention and cure
3.1.2 Market Restrain Analysis
3.1.2.1 Lack of regulatory approvals
3.1.2.2 Lack of proven results for nutrigenomics study support
3.2 Penetration & growth prospect mapping
3.3 Nutrigenomics - SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis - Porter's
Chapter 4 Nutrigenomics: Application Scope Estimates & Trend Analysis
4.1 Nutrigenomics market: application scope movement analysis
4.2 Obesity
4.2.1 Obesity Discovery market, 2014 - 2025 (USD Million)
4.3 Cardiovascular Diseases
4.3.1 Cardiovascular Diseases, 2014 - 2025 (USD Million)
4.4 Cancer research
4.4.1 Cancer research market, 2014 - 2025 (USD Million)
Chapter 5 Nutrigenomics: Regional Estimates & Trend Analysis, by Technique, Application, Indication Scope
5.1 Nutrigenomics market share by region, 2016 & 2025
5.2 North America
5.2.1 North America Nutrigenomics market, 2014-2025, (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. Nutrigenomics market, 2014-2025, (USD Million)
5.2.3 Canada
5.2.3.1 Canada Nutrigenomics market, 2014-2025, (USD Million)
5.3 Europe
5.3.1 Europe Nutrigenomics market, 2014-2025, (USD Million)
5.3.2 Germany
5.3.2.1 Germany Nutrigenomics market, 2014-2025, (USD Million)
5.3.3 U.K.
5.3.3.1 U.K. Nutrigenomics market, 2014-2025, (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Nutrigenomics market, 2014-2025, (USD Million)
5.4.2 China
5.4.2.1 China Nutrigenomics market, 2014-2025, (USD Million)
5.4.3 Japan
5.4.3.1 Japan Nutrigenomics market, 2014-2025, (USD Million)
5.5 Latin America
5.5.1 Latin America Nutrigenomics market, 2014-2025, (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil Nutrigenomics market, 2014-2025, (USD Million)
5.6 Middle East and Africa
5.6.1 Middle East and Africa Nutrigenomics market, 2014-2025, (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa Nutrigenomics market, 2014-2025, (USD Million)
Chapter 6 Competitive Landscape
6.1 Strategy framework
6.2 Market participation categorization
6.2.1 Royal DSM
6.2.1.1 Company overview
6.2.1.2 Financial performance
6.2.1.3 Technique benchmarking
6.2.1.4 Strategic initiatives
6.2.2 BASF
6.2.2.1 Company overview
6.2.2.2 Financial performance
6.2.2.3 Technique benchmarking
6.2.2.4 Strategic initiatives
6.2.3 Danone
6.2.3.1 Company overview
6.2.3.2 Financial performance
6.2.3.3 Technique benchmarking
6.2.3.4 Strategic initiatives
6.2.4 GeneSmart
6.2.4.1 overview
6.2.4.2 Financial performance
6.2.4.3 Technique benchmarking
6.2.4.4 Strategic initiatives
6.2.5 Unilever
6.2.5.1 overview
6.2.5.2 Financial performance
6.2.5.3 Technique benchmarking
6.2.5.4 Strategic initiatives
6.2.6 Genova Diagnostics
6.2.6.1 Company overview
6.2.6.2 Financial performance
6.2.6.3 Technique benchmarking
6.2.6.4 Strategic initiatives
6.2.7 Nutrigenomix, Inc,
6.2.7.1 Company overview
6.2.7.2 Financial performance
6.2.7.3 Technique benchmarking
6.2.7.4 Strategic initiatives
6.2.8 Metagenics
6.2.8.1 Company overview
6.2.8.2 Financial performance
6.2.8.3 Technique benchmarking
6.2.8.4 Strategic initiatives
6.2.9 Cell Logic
6.2.9.1 Company overview
6.2.9.2 Financial performance
6.2.9.3 Technique benchmarking
6.2.9.4 Strategic initiatives
6.2.10 WellGen
6.2.10.1 Company overview
6.2.10.2 Financial performance
6.2.10.3 Technique benchmarking
6.2.10.4 Strategic initiatives
List of Tables TABLE 1 North America Nutrigenomics market, by application scope, 2014 - 2025 (USD Million) TABLE 2 U.S. Nutrigenomics market, by application scope, 2014 - 2025 (USD Million) TABLE 3 Canada Nutrigenomics market, by application scope, 2014 - 2025 (USD Million) TABLE 4 Europe Nutrigenomics market, by application scope, 2014 - 2025 (USD Million) TABLE 5 Germany Nutrigenomics market, by application scope, 2014 - 2025 (USD Million) TABLE 6 U.K Nutrigenomics market, by application scope, 2014 - 2025 (USD Million) TABLE 7 Asia Pacific Nutrigenomics market, by application scope, 2014 - 2025 (USD Million) TABLE 8 China Nutrigenomics market, by application scope, 2014 - 2025 (USD Million) TABLE 9 Japan Nutrigenomics market, by application scope, 2014 - 2025 (USD Million) TABLE 10 Latin America Nutrigenomics market, by application scope, 2014 - 2025 (USD Million) TABLE 11 Brazil Nutrigenomics market, by application scope, 2014 - 2025 (USD Million) TABLE 12 Middle East and Africa Nutrigenomics market, by application scope, 2014 - 2025 (USD Million) TABLE 13 South Africa Nutrigenomics market, by application scope, 2014 - 2025 (USD Million) List of Figures FIG. 1 Market research process FIG. 2 Information procurement FIG. 3 Primary research pattern FIG. 4 Market research approaches FIG. 5 Value chain based sizing & forecasting FIG. 6 QFD modelling for market share assessment FIG. 7 Market summary FIG. 8 Market trends & outlook FIG. 9 Market segmentation & scope FIG. 10 Market driver relevance analysis (Current & future impact) FIG. 11 Market restrain relevance analysis (Current & future impact) FIG. 12 Penetration & growth prospect mapping FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological) FIG. 14 Porter's Five Forces Analysis FIG. 15 Nutrigenomics market application scope outlook: Key takeaways FIG. 16 Nutrigenomics market: application scope market: movement analysis FIG. 17 Global Obesity discovery market, 2014 - 2025 (USD Million) FIG. 18 Global Cardiovascular Diseases, 2014 - 2025 (USD Million) FIG. 19 Global Cancer research market, 2014 - 2025 (USD Million) FIG. 20 Regional market place: Key takeaways FIG. 21 Regional outlook, 2017 & 2025 FIG. 22 Strategy framework FIG. 23 Participant categorization
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
